Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years
NCT00290277
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL:
HPV-16/18 L1/AS04
Sponsor
GlaxoSmithKline